Materials and Methods: The data of breast cancer patients aged 65 and above who received treatment and follow-up at our clinic between 2012 and 2018 were retrospectively analyzed. Overall survival and disease-free survival analyses were performed using Kaplan-Meier analysis, and comparisons were conducted using the log-rank test.
Results: A total of 108 elderly female patients with breast cancer were included in the study. The median follow-up duration was 79.75 months (6.64 years), with a maximum follow-up of 133.49 months (11.12 years). At the end of this period, 88 patients (81.48%) were still alive. The 3-year overall survival rate was 93.5%, and the 5-year overall survival rate was 86.1%. The 3-year diseasefree survival rate was 91.6%, and the 5-year disease-free survival rate was 88.7%.
Conclusion: When making treatment decisions for elderly breast cancer patients, factors such as performance status, comorbidities, toxicity, and posttreatment quality of life should be carefully considered alongside age. Treatment decisions should be based on comprehensive evaluations taking these factors into account.
Keywords : Breast Neoplasms; Treatment Outcome; Aged; Mastectomy; Drug Therapy; Radiotherapy